Cibc World Markets Corp Myriad Genetics Inc Transaction History
Cibc World Markets Corp
- $14.8 Billion
- Q2 2025
A detailed history of Cibc World Markets Corp transactions in Myriad Genetics Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 11,218 shares of MYGN stock, worth $89,183. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,218
Previous 19,842
43.46%
Holding current value
$89,183
Previous $175,000
66.29%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MYGN
# of Institutions
234Shares Held
95.5MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$120 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$73.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$39.2 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$38.2 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$36.5 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $641M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...